Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

La Jolla scientists are stepping into a national push to get new medicines from lab bench to bedside faster. The project, ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Dana-Farber CEO outlines 2026 priorities: AI research, rare disease drug development, and plans for a new 300-bed hospital.

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...